glp-1 for autoimmune Agonists Improving Metabolic Health with Disease GLP-1 and autoimmune disease —

Endocrinology 144, 52155226

Why Physician-Supervised GLP-1 Programs Matter GLP-1 medications like semaglutide and tirzepatide have transformed the weight-loss landscape

Weeks 3 to 6: Measurable range-of-motion improvements

10.1038/s41574-022-00721-3 Nat Rev Endocrinol

What MOTS-c may help support More efficient use of carbohydrates as fuel Improved response to exercise and physical activity Increased cellular energy production When clinicians may consider MOTS-c Persistent fatigue despite adequate sleep Poor tolerance to carbohydrates Energy crashes after workouts or long workdays Metabolic recovery after GLP-1 therapy Instead of simply suppressing hunger, MOTS-c focuses on improving the bodys ability to produce and use energy effectively